$750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
Soulful Hands Home Care Expands Services for LGBTQ+ Seniors with Identity Affirming In-Home Care Chicago
Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Chicago
Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform
Global Patient Organizations Applaud Historic Passage of a Resolution at WHA 78: "Skin diseases as a global public health priority" Government
Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78 Government
Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement Government, Non-profit
CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)